PARIS, France—Relatively early results from a large registry of patients treated with the bioresorbable magnesium scaffold (Magmaris; Biotronik) suggests the device performs as well as ...
Efemoral Medical announced long-term results of the first 40 patients treated in the EFEMORAL I first-in-human (FIH) clinical ...
Abbott (NYSE:ABT) today shared promising 30-day results for its Esprit BTK everolimus-eluting resorbable scaffold system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results